Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
The federal minimum wage has remained $7.25 per hour since 2009. But several states, and even some companies, have since taken matters into their own hands to pay employees a...Workread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
A federal judge in California has blocked President Donald Trump from building sections of his long-sought border wall with money secured under his declaration of a national...Politicsread more
The Food and Drug Administration said Monday it sent warning letters to more than a dozen companies the agency said are "illegally selling" products that claim to prevent or cure Alzheimer's disease.
Many of these products, which are often sold on websites and social media platforms, "have not been reviewed by the FDA and are not proven safe and effective to treat the diseases and health conditions they claim to treat," the FDA said in a press release.
"These products may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment," the agency added.
As many as 5.5 million Americans over the age of 65 suffer from Alzheimer's, a progressive disease that often affects memory, thinking and behavior. The number of Americans with the disease is expected to grow, according to the Department of Health & Human Services.
The FDA is responsible for taking action against any misbranded dietary supplement product after it reaches the market.
More than 50 percent of U.S. adults use dietary supplements, the FDA says. Between 2007 and 2016 nearly 800 over-the-counter dietary supplements were found to contain unapproved drug ingredients, according to a study published in October.
The FDA said the products, which FDA Commissioner Scott Gottlieb labeled a "scam," have come in the form of tablets, capsules and oils. The 17 companies who were sent letters have been asked to respond within 15 days.